Cite
HARVARD Citation
Wells, P. et al. (2018). Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results. Journal of medical economics. pp. 587-594. [Online].